About Michael Porter
Michael Porter is a director at RESTOR3D.
Form D filings also name Michael Porter as a board member at Pressio Spine and a director at Huxley Medical.
Michael Porter first appears on SEC filings in 2024.
Experience
This experience comes from Michael Porter's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Porter in the role, so the role may have started earlier or lasted longer.
FF
Freedom Metals Acquisition Corp. (Nasdaq FDMMU) Current
Board Director, Audit Committee Chair & Investor
2026 – Present
AA
Avicanna Inc. (TSX:AVCN) Current
Strategic Investor & Board of Advisors
2026 – Present
AP
Altanova Pharma Current
Founder & Executive Chairman
2026 – Present
PG
PG Equity Group Current
Managing Partner & Founder
2025 – Present
RESTOR3D, Inc. Current
Board Member, Audit Committee Chair & Anchor Investor
2023 – Present · Durham, NC
Pressio, Inc. Current
Board Member, Audit Committee Chair & Anchor Investor
2021 – Present · San Antonio, TX
Pressio Spine develops spinal implants and surgical kits for surgeons and outpatient surgery centers.
Huxley Medical, Inc. Current
Board Member & Investor
2021 – Present · Atlanta, GA
Home sleep apnea testing for healthcare providers and their patients.
DU
Duke University Current
Advisor & Investor to MedTech Incubator
2020 – Present
SF
Steps of Hope Children's Foundation Current
Executive Chairman & Founder
2008 – Present
CH
Ciraparantag Holdings
Executive Chairman, Board of Managers
2022 – 2025
CP
Covis Pharma
CEO & Board Member
2013 – 2025
CM
Cerberus Capital Management
COAC - Senior Operating Partner
2010 – 2013
SI
Sun Capital Partners, Inc.
Managing Director - Level 3
2007 – 2010
AL
AlixPartners
Senior Director
2002 – 2007
SL
Schultze Asset Management, LP
Vice President
2000 – 2002
BA
Bank of America
Financial Analyst
1996 – 1999
Key Colleagues at Startups
The people Michael Porter works with at each company, as listed on that company's latest Form D.
Pressio, Inc. · Form D, Oct 6, 2026
JB
Jeremy Blair
Board Member
JE
John Ellington
Chief Executive Officer and director
GG
Gaetano Guglielmino
Director
Huxley Medical, Inc. · Form D, Sep 30, 2026
KJ
Kurt Jacobus
Director
CL
Christopher Lee
Chief Executive Officer and director
KG
Kenneth Gall
Director
DB
Drew Beaver
Director
WC
William Cox
Director
BT
Brennan Torstrick
President and Chief Scientific Officer, director
RESTOR3D, Inc. · Form D, Aug 22, 2025
KJ
Kurt Jacobus
Executive officer and director
AS
Andrew Summers
Director
AM
Andrew Miller
Executive officer
GA
Greg Anglum
Chief Financial Officer
KG
Kenneth Gall
Executive officer
DK
Douglas Kohrs
Director
EW
Erich Wolff
Director
Cambre Kelly
Executive officer
BN
Brian Neiswender
Director
SH
Stuart Huston
Director